Physician profile
Natalie Gregory
NPI 1235285859
$1,170.28
in general payments reported to CMS, 2019-2025
17 companies · $487 in 2025
The $487 reported for 2025 was more than what 80% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $75.94 · 2020: $121 · 2021: $14.37 · 2022: $244 · 2023: $101 · 2024: $127 · 2025: $487.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $715.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $714.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $245.01 | 2025 | |
| Therapeuticsmd, INC. | $167.81 | 2019-2020 | |
| Medtronic, INC. | $125.89 | 2022 | |
| Optumhealth Care Solutions, LLC | $105.39 | 2023-2025 | Vivify Health Care Team Portal, Eitan Medical, Vivify Health Care Team Portal 001 |
| Axonics, INC. | $102.66 | 2022 | |
| Astellas Pharma US INC | $95.74 | 2024 | Veozah |
| Hologic Sales and Service, LLC | $51.69 | 2025 | Aptima, Novasure, Myosure Tissue Removal Device |
| Pfizer INC. | $41.24 | 2023 | |
| Exeltis, USA INC. | $40.02 | 2025 | Slynd |
| Organon LLC | $33.59 | 2022-2025 | Nexplanon |
| Innovation Technologies INC | $30.00 | 2025 | Irrisept |
| Medela LLC | $28.86 | 2020 | |
| Sumitomo Pharma America, INC. | $28.18 | 2025 | Myfembree |
| Shield Therapeutics INC | $23.44 | 2025 | |
| Millicent US INC | $19.05 | 2025 | Intrarosa, Femlyv |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $17.34 | 2025 | |
| Ethicon US, LLC | $14.37 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Natalie Gregory listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.